P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE

ABSTRACT:

SUBMITTER: D’agostino M 

PROVIDER: S-EPMC10430276 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature